MCID: THR004
MIFTS: 51

Thrombocytosis

Categories: Blood diseases

Aliases & Classifications for Thrombocytosis

MalaCards integrated aliases for Thrombocytosis:

Name: Thrombocytosis 12 74 29 54 43 15 71
Thrombocythaemia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2228
MeSH 43 D013922
NCIt 49 C35530
SNOMED-CT 67 6631009 79574003
UMLS 71 C0836924

Summaries for Thrombocytosis

Disease Ontology : 12 A blood platelet disease that is characterized by the presence of high platelet counts in the blood.

MalaCards based summary : Thrombocytosis, also known as thrombocythaemia, is related to transient erythroblastopenia of childhood and splenomegaly. An important gene associated with Thrombocytosis is JAK2 (Janus Kinase 2), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs tannic acid and Benzocaine have been mentioned in the context of this disorder. Affiliated tissues include myeloid, bone and bone marrow, and related phenotypes are hematopoietic system and immune system

Wikipedia : 74 Thrombocythemia, also called thrombocytosis and thrombophilia, is the presence of a high platelet... more...

Related Diseases for Thrombocytosis

Diseases related to Thrombocytosis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 731, show less)
# Related Disease Score Top Affiliating Genes
1 transient erythroblastopenia of childhood 32.5 KITLG EPO
2 splenomegaly 31.5 MPL JAK2 EPO
3 iron deficiency anemia 31.3 THPO IL6 EPO CRP
4 refractory anemia 31.3 TET2 MPL IL3 EPO CSF3
5 myelodysplastic/myeloproliferative neoplasm 31.2 TET2 JAK2 CSF2
6 polycythemia vera 31.0 THPO TET2 SELP MPL KITLG JAK2
7 paraneoplastic syndromes 31.0 IL6 CSF3
8 thrombophilia due to thrombin defect 30.9 SERPINC1 F3 F2
9 blood platelet disease 30.8 THPO SERPINC1 SELP MPL JAK2 IL6
10 essential thrombocythemia 30.8 THPO TET2 SERPINC1 SELP PPBP MPL
11 granulocytopenia 30.7 IL3 CSF3 CSF2
12 platelet aggregation, spontaneous 30.7 SERPINC1 SELP
13 osteomyelitis 30.7 IL6 IL1B CSF3
14 osteosclerotic myeloma 30.7 IL6 IL1B
15 myeloid leukemia 30.7 TET2 LIF JAK2 IL3 CSF3 CSF2
16 erythrocytosis, familial, 1 30.6 JAK2 IL3 EPO
17 acute leukemia 30.6 THPO JAK2 IL3 CSF3 CSF2
18 acute cystitis 30.6 IL6 F2 CRP
19 coronary thrombosis 30.6 SERPINC1 SELP F3
20 portal hypertension 30.5 THPO JAK2 F3 F2
21 lateral sinus thrombosis 30.5 SERPINC1 F2
22 thrombocytopenic purpura, autoimmune 30.5 THPO SELP MPL IL11
23 pulmonary embolism 30.5 SERPINC1 F3 F2 CRP
24 amegakaryocytic thrombocytopenia, congenital 30.5 THPO MPL JAK2 IL3
25 intracranial hypertension 30.5 SERPINC1 IL1B F3 F2
26 thrombocytopenia due to platelet alloimmunization 30.4 THPO SELP MPL
27 heparin-induced thrombocytopenia 30.4 SERPINC1 F3
28 budd-chiari syndrome 30.4 SERPINC1 MPL JAK2 F3 F2
29 bacterial meningitis 30.4 IL6 IL1B CSF2 CRP
30 thrombophilia due to activated protein c resistance 30.4 SERPINC1 F3 F2
31 angina pectoris 30.4 IL6 F3 CRP
32 sagittal sinus thrombosis 30.3 SERPINC1 F3 F2
33 poems syndrome 30.3 IL6 IL1B EPO CSF3
34 active peptic ulcer disease 30.3 F3 F2 CRP
35 polyarteritis nodosa 30.3 SELP IL6 CRP
36 iritis 30.3 IL6 EPO CRP
37 portal vein thrombosis 30.3 SERPINC1 SELP MPL JAK2 F2 CRP
38 spinal cord infarction 30.3 SERPINC1 F2
39 nonarteritic anterior ischemic optic neuropathy 30.3 SERPINC1 F2 CRP
40 acute monoblastic leukemia 30.3 IL6 EPO CSF2
41 polyneuropathy 30.3 IL6 IL1B EPO CRP
42 relapsing polychondritis 30.3 IL6 CSF3 CRP
43 systemic mastocytosis 30.3 TET2 KITLG JAK2
44 vitamin k deficiency bleeding 30.3 SERPINC1 F3 F2
45 peripheral nervous system disease 30.2 IL6 IL1B CSF3 CRP
46 eosinophilic gastroenteritis 30.2 IL3 CSF3 CSF2
47 meningitis 30.2 IL6 IL1B CSF3 CSF2 CRP
48 proteasome-associated autoinflammatory syndrome 1 30.2 SELP IL6 IL1B CRP
49 cavernous sinus thrombosis 30.2 SERPINC1 F2 CRP
50 cholesterol embolism 30.2 SERPINC1 F2 CRP
51 end stage renal failure 30.1 SELP IL6 EPO CRP
52 varicose veins 30.1 SERPINC1 IL6 F2
53 cerebrovascular disease 30.1 SELP IL6 F2 CRP
54 perinatal necrotizing enterocolitis 30.1 THPO IL6 IL1B CRP
55 pulmonary disease, chronic obstructive 30.1 IL6 IL1B CSF2 CRP
56 retinal vein occlusion 30.1 SERPINC1 IL6 F3 F2
57 von willebrand's disease 30.1 SELP F3 F2
58 ileus 30.1 IL6 IL1B F2 CSF2 CRP
59 splenic sequestration 30.1 THPO MPL F3 F2 EPO
60 thrombosis 30.1 SERPINC1 SELP PPBP MPL JAK2 F3
61 exudative vitreoretinopathy 1 30.1 IL6 EPO CRP
62 bacterial pneumonia 30.1 IL6 CSF3 CRP
63 neutrophilia, hereditary 30.1 JAK2 IL6 IL3 CSF3 CSF2 CRP
64 bacterial infectious disease 30.1 IL6 IL3 IL1B CSF3 CSF2 CRP
65 pyoderma 30.1 F3 CSF3 CRP
66 papilledema 30.1 SERPINC1 F3 F2 CRP
67 atrophic gastritis 30.1 IL6 IL1B IL11
68 mastocytosis 30.1 TET2 KITLG JAK2 IL6 IL3
69 polycythemia 30.0 THPO TET2 PPBP MPL KITLG JAK2
70 rheumatoid arthritis 30.0 LIF IL6 IL1B IL11 CSF2 CRP
71 leptospirosis 30.0 IL6 IL1B F2 CRP
72 pharyngitis 30.0 IL6 IL1B CSF2 CRP
73 lymphoma, hodgkin, classic 30.0 JAK2 IL3 CSF3 CSF2
74 mucositis 30.0 IL3 IL11 CSF3 CSF2
75 alcoholic hepatitis 30.0 IL6 IL1B F2 CRP
76 exanthem 30.0 IL6 F3 F2 CSF3 CSF2 CRP
77 cerebral palsy 30.0 IL6 IL1B F2 CSF3
78 gastroenteritis 30.0 IL6 IL3 IL1B CSF3 CSF2 CRP
79 arteries, anomalies of 30.0 SELP IL6 F3 CRP
80 qualitative platelet defect 30.0 F3 F2
81 acute myocardial infarction 30.0 SERPINC1 SELP PPBP IL6 F3 CRP
82 paroxysmal nocturnal hemoglobinuria 30.0 SERPINC1 F2 CSF3
83 bilirubin metabolic disorder 30.0 F3 F2 CRP
84 central retinal vein occlusion 30.0 SERPINC1 JAK2 IL6 F3 F2
85 mastocytosis, cutaneous 30.0 TET2 KITLG IL3
86 antiphospholipid syndrome 30.0 SERPINC1 SELP F3 F2 CRP
87 chronic myelomonocytic leukemia 30.0 TET2 MPL JAK2 CSF3 CSF2
88 intracranial thrombosis 29.9 SERPINC1 SELP F3 F2
89 splenic infarction 29.9 SERPINC1 JAK2 F3 F2 CRP
90 liver cirrhosis 29.9 THPO SERPINC1 F3 F2
91 sickle cell anemia 29.9 KITLG IL6 F2 EPO CSF3
92 monocytic leukemia 29.9 IL6 IL1B F3 CSF2
93 compartment syndrome 29.9 SERPINC1 IL6 F3 F2 CRP
94 disseminated intravascular coagulation 29.9 SERPINC1 IL6 F3 F2 CRP
95 purpura 29.9 THPO SERPINC1 SELP MPL IL6 F3
96 myelofibrosis 29.9 THPO TET2 SELP MPL JAK2 IL3
97 myeloma, multiple 29.9 JAK2 IL6 IL3 IL11 EPO CSF3
98 leukemia, acute myeloid 29.9 THPO TET2 MPL KITLG JAK2 IL6
99 intracranial embolism 29.9 SERPINC1 F3 F2 CRP
100 pancytopenia 29.8 THPO MPL IL6 IL3 EPO CSF3
101 pneumonia 29.8 IL6 IL1B IL11 F3 F2 CSF3
102 intermediate coronary syndrome 29.8 SERPINC1 SELP IL6 F3 CRP
103 thrombophilia 29.8 SERPINC1 SELP PPBP JAK2 F3 F2
104 plasmacytoma 29.8 LIF IL6 IL11
105 patent foramen ovale 29.8 SERPINC1 F3 F2 CRP
106 anemia of prematurity 29.8 EPO CSF2
107 hemorrhagic disease 29.8 SERPINC1 PPBP F3 F2 CRP
108 placental insufficiency 29.8 SERPINC1 SELP IL6 F3 F2
109 thrombophlebitis 29.7 SERPINC1 SELP F3 F2 CRP
110 peritonitis 29.7 SELP IL6 IL1B F2 CSF3 CRP
111 systemic scleroderma 29.7 SELP KITLG IL6 CRP
112 migraine with or without aura 1 29.7 PPBP IL6 IL1B F2 CRP
113 lung disease 29.7 IL6 IL1B F3 CSF3 CSF2 CRP
114 megakaryocytic leukemia 29.7 THPO SELP KITLG JAK2 IL3 IL11
115 toxic shock syndrome 29.7 SERPINC1 IL6 IL1B F3 CRP
116 takayasu arteritis 29.7 SERPINC1 IL6 F3 F2 CRP
117 myelodysplastic syndrome 29.6 THPO TET2 MPL KITLG JAK2 IL6
118 pulmonary hypertension 29.6 SERPINC1 SELP IL6 IL1B F3 F2
119 hypersplenism 29.6 THPO SERPINC1 F2 EPO CSF3 CSF2
120 myeloproliferative neoplasm 29.5 THPO TET2 SELP MPL KITLG JAK2
121 lymphoma, non-hodgkin, familial 29.5 KITLG JAK2 IL6 IL3 CSF3 CSF2
122 placenta disease 29.5 SERPINC1 IL6 IL1B F3 F2 CRP
123 deficiency anemia 29.4 THPO SELP MPL LIF KITLG JAK2
124 hemoglobinuria 29.3 THPO SERPINC1 SELP MPL F2 EPO
125 coronary artery anomaly 29.3 SERPINC1 SELP IL6 IL1B F3 F2
126 leukemia, acute lymphoblastic 29.3 THPO SERPINC1 MPL KITLG JAK2 IL3
127 vascular disease 29.3 SERPINC1 SELP PPBP IL6 F3 F2
128 systemic lupus erythematosus 29.2 SELP JAK2 IL6 IL1B F3 F2
129 pre-eclampsia 29.2 SERPINC1 SELP PPBP IL6 IL1B F3
130 leukemia, chronic myeloid 29.1 THPO SELP MPL KITLG JAK2 IL3
131 osteoporosis 29.1 SERPINC1 LIF IL6 IL1B IL11 F3
132 peripheral vascular disease 29.1 SERPINC1 SELP PPBP IL6 F3 F2
133 atrial fibrillation 29.0 SERPINC1 SELP PPBP IL6 F3 F2
134 stroke, ischemic 29.0 SERPINC1 SELP PPBP IL6 F3 F2
135 dermatitis, atopic 29.0 SELP PPBP KITLG IL6 IL3 IL1B
136 neutropenia 28.9 THPO MPL KITLG IL6 IL3 IL11
137 inflammatory bowel disease 28.8 SERPINC1 SELP JAK2 IL6 IL3 IL1B
138 heart disease 28.8 SERPINC1 SELP PPBP IL6 IL1B F3
139 myocardial infarction 28.8 SERPINC1 SELP PPBP KITLG IL6 IL1B
140 acute promyelocytic leukemia 28.5 SERPINC1 SELP KITLG IL6 IL3 IL1B
141 thrombocytopenia 28.2 THPO SERPINC1 SELP PPBP MPL KITLG
142 thrombocythemia 1 12.1
143 thrombocythemia 3 11.7
144 temporal arteritis 11.5
145 thrombocythemia 2 11.5
146 erythromelalgia 11.5
147 thrombocythemia, x-linked 11.5
148 thrombocythemia with distal limb defects 11.3
149 vibrio vulnificus infection 10.7 IL6 EPO
150 thrombocytopenia 3 10.7 THPO MPL
151 acute radiation syndrome 10.7 EPO CSF3
152 mixed lacrimal gland cancer 10.7 JAK2 IL6
153 ovarian clear cell cystadenocarcinoma 10.6 EPO CSF3
154 ovarian clear cell malignant adenofibroma 10.6 EPO CSF3
155 mixed epithelial tumor of ovary 10.6 EPO CSF3
156 fallopian tube transitional cell carcinoma 10.6 EPO CSF3
157 fallopian tube mucinous adenocarcinoma 10.6 EPO CSF3
158 orbital osteomyelitis 10.6 F2 CRP
159 acquired polycythemia 10.6 MPL JAK2 EPO
160 cold agglutinin disease 10.6 IL6 CRP
161 acquired thrombocytopenia 10.6 THPO MPL IL11
162 small intestine diverticulitis 10.6 F2 CRP
163 cardiogenic shock 10.6 IL6 CRP
164 periodontitis, chronic 10.6 IL6 IL1B
165 cryopyrin-associated periodic syndrome 10.6 IL6 CRP
166 iron metabolism disease 10.6
167 folic acid deficiency anemia 10.6 EPO CRP
168 cardiac tuberculosis 10.6 SERPINC1 CRP
169 systemic autoimmune disease 10.6 IL6 CRP
170 dyskeratosis congenita, autosomal dominant 6 10.6 THPO MPL
171 b-cell growth factor 10.6 IL6 IL3
172 idiopathic neutropenia 10.6 THPO IL6 IL1B
173 large granular lymphocyte leukemia 10.6 CSF3 CSF2
174 chronic neutrophilic leukemia 10.5 TET2 JAK2 CSF3
175 myeloid and lymphoid neoplasms associated with pdgfra rearrangement 10.5 JAK2 EPO CSF2
176 prosthetic joint infection 10.5 IL6 IL1B CRP
177 uremic pruritus 10.5 IL6 IL1B CRP
178 engraftment syndrome 10.5 CSF3 CSF2
179 miliary tuberculosis 10.5 EPO CSF3 CRP
180 myelophthisic anemia 10.5 TET2 MPL JAK2 EPO
181 laryngitis 10.5 IL6 IL1B CRP
182 polyradiculopathy 10.5 IL6 IL1B CRP
183 funisitis 10.5 IL6 IL1B CRP
184 pneumocystosis 10.5 IL6 CSF3 CRP
185 palladium allergic contact dermatitis 10.5 IL1B CSF2
186 acute cholangitis 10.5 IL6 F2 CRP
187 subacute thyroiditis 10.5 IL6 IL1B CRP
188 chronic recurrent multifocal osteomyelitis 10.5 IL6 IL1B CRP
189 gastric hemangioma 10.5 F3 F2
190 acute vascular insufficiency of intestine 10.5 SERPINC1 IL6
191 necrotizing gastritis 10.5 F2 CRP
192 acute pyelonephritis 10.5 IL6 CSF3 CRP
193 gingival disease 10.5 IL6 IL1B CRP
194 vaginal disease 10.5 IL6 IL1B CRP
195 adult-onset still's disease 10.5 IL6 IL1B CRP
196 cecal disease 10.5 IL6 F2 CRP
197 neutropenia, severe congenital, 3, autosomal recessive 10.5 IL3 CSF3 CSF2
198 sebaceous gland disease 10.5 IL6 IL1B CRP
199 primary systemic mycosis 10.5 IL6 CSF2 CRP
200 middle ear disease 10.5 IL6 IL1B CRP
201 conjunctival disease 10.5 IL6 IL1B CRP
202 dysentery 10.5 IL6 IL1B CRP
203 retinal artery occlusion 10.5 SERPINC1 IL6 F2
204 meconium aspiration syndrome 10.5 IL6 CSF3 CSF2
205 papillary adenofibroma 10.5 F3 F2
206 capillary leak syndrome 10.5 IL6 CSF3 CSF2
207 gastroschisis 10.5 IL6 IL1B F2
208 sudden sensorineural hearing loss 10.5 SERPINC1 IL6 F2
209 preterm premature rupture of the membranes 10.5 IL6 IL1B CRP
210 drug-induced lupus erythematosus 10.5 IL6 IL1B CSF2
211 felty syndrome 10.5 IL3 CSF3 CSF2
212 sm-ahnmd 10.5 TET2 KITLG JAK2
213 cinca syndrome 10.5 IL6 IL1B CRP
214 extrinsic cardiomyopathy 10.5 IL6 IL1B CRP
215 vulvar angiokeratoma 10.5 SERPINC1 F3
216 retinitis pigmentosa and erythrocytic microcytosis 10.5 JAK2 IL3 EPO CSF3
217 nasal cavity disease 10.5 IL6 IL3 CSF2
218 lymphoid interstitial pneumonia 10.5 IL6 CSF2 CRP
219 indolent myeloma 10.5 IL6 IL1B
220 waterhouse-friderichsen syndrome 10.5 SERPINC1 F2
221 antithrombin iii deficiency 10.5 SERPINC1 JAK2 F2
222 commensal bacterial infectious disease 10.5 IL6 IL1B CRP
223 hantavirus hemorrhagic fever with renal syndrome 10.5 IL6 F3 CRP
224 respiratory allergy 10.5 IL6 IL3 CSF2
225 pericarditis 10.5 IL6 IL1B CRP
226 necrotizing fasciitis 10.4 IL6 F3 CRP
227 endogenous depression 10.4 IL6 IL1B CRP
228 yellow fever 10.4 IL6 IL1B CRP
229 obstructive jaundice 10.4 IL6 F2 CRP
230 multicentric castleman disease 10.4 IL6 F3 CRP
231 mastoiditis 10.4 SERPINC1 F2 CRP
232 hypersensitivity reaction type iii disease 10.4 SELP IL6 CRP
233 extracutaneous mastocytoma 10.4 TET2 KITLG
234 aphthous stomatitis 10.4 IL6 IL1B CSF2
235 ecthyma 10.4 CSF3 CRP
236 central retinal artery occlusion 10.4 SERPINC1 F2 CRP
237 synovial angioma 10.4 F3 F2 CRP
238 renal pelvis squamous cell carcinoma 10.4 F3 F2 CRP
239 emphysematous cholecystitis 10.4 F3 F2 CRP
240 lemierre's syndrome 10.4 F3 F2 CRP
241 encephalomalacia 10.4 IL6 IL1B EPO CRP
242 gingivitis 10.4 IL6 IL1B CSF3
243 familial mediterranean fever 10.4 IL6 IL1B CRP
244 cardiac tamponade 10.4 F3 F2 CRP
245 anuria 10.4 F3 F2 CRP
246 tricuspid valve insufficiency 10.4 F3 F2 CRP
247 tricuspid valve disease 10.4 F3 F2 CRP
248 scrub typhus 10.4 IL1B F3 CRP
249 alcoholic liver cirrhosis 10.4 IL6 IL1B F2
250 femoral neuropathy 10.4 F3 F2
251 nutritional deficiency disease 10.4 IL6 F2 EPO CRP
252 reactive arthritis 10.4 IL6 IL1B CRP
253 leprosy 3 10.4 IL6 IL1B CSF2
254 appendicitis 10.4 IL6 IL1B CSF3 CRP
255 pyelonephritis 10.4 IL6 IL1B CSF3 CRP
256 lyme disease 10.4 IL6 IL1B CRP
257 nose disease 10.4 IL6 IL3 CSF2 CRP
258 fournier gangrene 10.4 SERPINC1 F3 F2
259 null-cell leukemia 10.4 LIF IL6
260 dic in newborn 10.4 SERPINC1 F3 F2
261 mouth disease 10.4 JAK2 IL6 IL1B CRP
262 brain edema 10.4 IL6 IL1B CSF3 CRP
263 hepatic infarction 10.4 SERPINC1 F3 F2
264 giant hemangioma 10.4 SERPINC1 F3 F2
265 prothrombin deficiency 10.4 SERPINC1 F3 F2
266 volkmann contracture 10.4 SERPINC1 F3 F2
267 opportunistic mycosis 10.4 IL6 CSF3 CSF2 CRP
268 smallpox 10.4 IL1B CSF3 CSF2
269 chronic venous insufficiency 10.4 SELP F2 CRP
270 dengue hemorrhagic fever 10.4 IL6 F3 F2
271 typhoid fever 10.4 IL6 IL1B F2 CRP
272 venous insufficiency 10.4 SELP F2 CRP
273 common cold 10.4 SELP IL6 CSF2
274 pleural disease 10.4 IL6 IL1B F2 CRP
275 castleman disease 10.4 IL6 CSF3 CSF2 CRP
276 pyomyositis 10.4 CSF3 CRP
277 ovarian cancer 10.4
278 esophageal varix 10.4 SERPINC1 F3 F2
279 ischemic colitis 10.3 SERPINC1 JAK2 F2 CRP
280 chorioamnionitis 10.3 IL6 IL1B CSF2 CRP
281 chlamydia 10.3 IL6 IL1B CSF2 CRP
282 adult respiratory distress syndrome 10.3 IL6 IL1B F2 CSF3
283 livedoid vasculitis 10.3 SERPINC1 F2
284 bronchial disease 10.3 IL6 IL1B CSF2 CRP
285 primary bacterial infectious disease 10.3 IL6 IL1B CSF2 CRP
286 factor xiii deficiency 10.3 SERPINC1 F3 F2
287 purpura fulminans 10.3 SERPINC1 F3 F2
288 juvenile myelomonocytic leukemia 10.3 TET2 JAK2 IL1B CSF2
289 stomatitis 10.3 IL6 IL1B CSF3 CSF2
290 factor xi deficiency 10.3 SERPINC1 F3 F2
291 chronic mucocutaneous candidiasis 10.3 IL6 IL1B CSF3 CSF2
292 aspergillosis 10.3 IL6 IL1B CSF3 CSF2
293 bone inflammation disease 10.3 IL6 IL1B CSF2 CRP
294 factor vii deficiency 10.3 SERPINC1 F3 F2
295 protein s deficiency 10.3 SERPINC1 F3 F2
296 leukemia 10.3
297 tetanus 10.3 IL6 IL1B CSF2 CRP
298 thrombasthenia 10.3 SELP F3 F2
299 lymphatic system disease 10.3 IL6 CSF2 CRP
300 interstitial lung disease 10.3 IL6 IL1B CSF2 CRP
301 infective endocarditis 10.3 PPBP IL6 F2 CRP
302 renal cell carcinoma, nonpapillary 10.3
303 stachybotrys chartarum 10.3 LIF IL6 IL3 IL1B
304 heart conduction disease 10.3 F3 F2 CRP
305 analbuminemia 10.3 F3 F2 EPO CRP
306 aspiration pneumonia 10.3 IL6 F3 F2 CRP
307 pericardium disease 10.3 IL6 F3 F2 CRP
308 endocardium disease 10.3 IL6 F3 F2 CRP
309 immune system disease 10.3 IL6 IL1B CSF2 CRP
310 pericardial effusion 10.3 IL6 F3 F2 CRP
311 mycoplasma pneumoniae pneumonia 10.3 IL6 F3 CSF2 CRP
312 splenic abscess 10.3 F2 CRP
313 homocysteinemia 10.3 SERPINC1 F2 CRP
314 moyamoya disease 1 10.3 SERPINC1 F3 F2
315 hepatic veno-occlusive disease 10.3 THPO SERPINC1 F3 CSF3
316 fibromyalgia 10.3 IL6 IL1B CRP
317 retinal vascular disease 10.3 LIF IL6 IL1B CRP
318 hemophilia b 10.3 SERPINC1 F3 F2
319 bone disease 10.3 IL6 IL3 IL1B IL11 EPO
320 carotid artery disease 10.3 SELP F3 CRP
321 ascending cholangitis 10.3 F2 CRP
322 thoracic outlet syndrome 10.3 SERPINC1 F2
323 speech and communication disorders 10.3 IL6 F3 F2 CRP
324 post-thrombotic syndrome 10.3 SERPINC1 IL6 F3 F2
325 heart valve disease 10.3 IL1B F3 F2 CRP
326 bernard-soulier syndrome 10.3 THPO SELP F2
327 blood protein disease 10.3 SERPINC1 IL6 F3 F2
328 autoimmune disease of blood 10.3 THPO MPL IL6 F3 F2
329 endometrial cancer 10.2
330 autosomal recessive pyridoxine-refractory sideroblastic anemia 2 10.2
331 blue toe syndrome 10.2 SERPINC1 F3 F2 CRP
332 marantic endocarditis 10.2 SERPINC1 F3 F2 CRP
333 intracranial sinus thrombosis 10.2 SERPINC1 F3 F2 CRP
334 branch retinal artery occlusion 10.2 SERPINC1 F3 F2 CRP
335 parasitic protozoa infectious disease 10.2 IL6 CSF2 CRP
336 peripheral vertigo 10.2 SERPINC1 F3 F2 CRP
337 peripheral artery disease 10.2 SELP IL6 F3 CRP
338 acquired immunodeficiency syndrome 10.2 IL6 IL1B EPO CSF2 CRP
339 thrombotic thrombocytopenic purpura 10.2 SERPINC1 SELP F3
340 lung cancer 10.2
341 ovarian epithelial cancer 10.2
342 afibrinogenemia, congenital 10.2 SERPINC1 F3 F2
343 atrial heart septal defect 10.2 SERPINC1 F3 F2 CRP
344 arthritis 10.2
345 sleep apnea 10.2 SELP IL6 IL1B EPO CRP
346 intracranial berry aneurysm 10.2 IL6 F3 CRP
347 epidural abscess 10.2 F3 CRP
348 colorectal cancer 10.2
349 cervical cancer 10.2
350 glanzmann thrombasthenia 10.2 SELP F3 F2
351 dyskeratosis congenita 10.1 KITLG EPO CSF3 CSF2
352 inherited blood coagulation disease 10.1 SERPINC1 SELP F3 F2
353 carotid artery thrombosis 10.1 SERPINC1 SELP F3 CSF2
354 primary thrombocytopenia 10.1 THPO SELP MPL F3 F2
355 chromosome 5q deletion syndrome 10.1
356 benign mesothelioma 10.1
357 endocarditis 10.1 SERPINC1 PPBP IL6 F2 CRP
358 severe congenital neutropenia 10.1 KITLG JAK2 IL3 CSF3 CSF2
359 hemolytic-uremic syndrome 10.1 SELP F3 F2
360 liver disease 10.1 THPO IL6 IL1B F3 F2
361 hellp syndrome 10.1 SERPINC1 IL6 F3 F2 CRP
362 retinal vascular occlusion 10.1 SERPINC1 SELP IL6 F2 CRP
363 kawasaki disease 10.1
364 crohn's disease 10.1
365 chromosomal triplication 10.1
366 intermittent claudication 10.1 SERPINC1 SELP IL6 F2 CRP
367 cyclic neutropenia 10.1 KITLG IL3 IL1B CSF3 CSF2
368 atherosclerosis susceptibility 10.1 SELP IL6 IL1B F3 CRP
369 small cell cancer of the lung 10.1
370 gastric cancer 10.1
371 thalassemia 10.1
372 hemolytic anemia 10.1
373 hypereosinophilic syndrome 10.1
374 behcet syndrome 10.1 SERPINC1 JAK2 IL6 IL1B F2 CRP
375 severe combined immunodeficiency 10.1 KITLG IL6 IL3 CSF3 CSF2
376 hepatoblastoma 10.1
377 splenic disease 10.0 THPO IL6 F3 F2 CSF2 CRP
378 pulmonary edema 10.0 SERPINC1 IL1B F2 EPO CSF3 CRP
379 vein disease 10.0 SERPINC1 JAK2 IL6 F3 F2 CRP
380 pain agnosia 10.0
381 autoimmune disease 10.0
382 bladder cancer 10.0
383 caffey disease 10.0
384 hepatocellular carcinoma 10.0
385 beta-thalassemia 10.0
386 colitis 10.0
387 squamous cell carcinoma 10.0
388 macrocytic anemia 10.0
389 bronchiolitis 10.0
390 ulcerative colitis 10.0
391 vasculitis 10.0
392 neuropathy 10.0
393 lupus erythematosus 10.0
394 leech infestation 10.0 SERPINC1 F3
395 cardiovascular system disease 10.0 SERPINC1 SELP IL6 F3 CRP
396 breast cancer 10.0
397 hypercholesterolemia, familial, 1 10.0
398 mesothelioma, malignant 10.0
399 thrombocytopenia, cyclic 10.0
400 suppressor of tumorigenicity 3 10.0
401 yemenite deaf-blind hypopigmentation syndrome 10.0
402 acquired von willebrand syndrome 10.0
403 rectum cancer 10.0
404 hyperostosis 10.0
405 eosinophilic pneumonia 10.0
406 lymphopenia 10.0
407 chronic eosinophilic pneumonia 10.0
408 sickle cell disease 10.0
409 diamond-blackfan anemia 10.0 THPO MPL KITLG JAK2 IL3 EPO
410 prothrombin deficiency, congenital 9.9 SERPINC1 F2
411 pulmonary artery disease 9.9 SERPINC1 SELP IL6 F3 F2 CRP
412 esophageal cancer 9.9
413 down syndrome 9.9
414 lipoid congenital adrenal hyperplasia 9.9
415 celiac disease 1 9.9
416 pancreatic cancer 9.9
417 limb ischemia 9.9
418 ptosis 9.9
419 cardiac arrest 9.9
420 lymphocytic leukemia 9.9
421 q fever 9.9
422 nephrotic syndrome 9.9
423 hemosiderosis 9.9
424 alcohol use disorder 9.9
425 peritoneal mesothelioma 9.9
426 optic nerve disease 9.9
427 hepatitis 9.9
428 dermatitis 9.9
429 glomerulonephritis 9.9
430 pulmonary tuberculosis 9.9
431 pleural empyema 9.9
432 syphilis 9.9
433 pustulosis of palm and sole 9.9
434 large cell carcinoma 9.9
435 inferior myocardial infarction 9.9
436 paraplegia 9.9
437 juvenile rheumatoid arthritis 9.9
438 malignant pleural mesothelioma 9.9
439 psoriasis 9.9
440 sideroblastic anemia 9.9
441 48,xyyy 9.9
442 cytokine deficiency 9.9
443 rare hereditary hemochromatosis 9.9
444 rare disease in surgical orthopedic 9.9
445 primary polycythemia 9.9 THPO TET2 MPL JAK2 IL3 EPO
446 arteriosclerosis 9.9 SERPINC1 SELP IL6 F3 CSF2 CRP
447 erythermalgia, primary 9.9
448 telangiectasia, hereditary hemorrhagic, type 1 9.9
449 arterial calcification, generalized, of infancy, 1 9.9
450 microvascular complications of diabetes 1 9.9
451 microvascular complications of diabetes 2 9.9
452 microvascular complications of diabetes 5 9.9
453 angiosarcoma 9.9
454 allergic hypersensitivity disease 9.9
455 telangiectasis 9.9
456 endometriosis 9.9
457 pyoderma gangrenosum 9.9
458 bone marrow necrosis 9.9
459 primary cutaneous follicle center lymphoma 9.9
460 pik3ca-related overgrowth syndrome 9.9
461 bone marrow cancer 9.9 THPO TET2 MPL JAK2 IL6 IL3
462 respiratory failure 9.8 PPBP IL6 IL1B F3 F2 EPO
463 mitral valve stenosis 9.8 SERPINC1 SELP PPBP F3 F2 CRP
464 neurofibromatosis, type iv, of riccardi 9.8
465 dowling-degos disease 1 9.8
466 sarcoidosis 1 9.8
467 scleroderma, familial progressive 9.8
468 anemia, autoimmune hemolytic 9.8
469 langerhans cell histiocytosis 9.8
470 meningioma, radiation-induced 9.8
471 meningioma, familial 9.8
472 coronary heart disease 1 9.8
473 psoriatic arthritis 9.8
474 lung cancer susceptibility 3 9.8
475 cyanosis, transient neonatal 9.8
476 hyperlipoproteinemia, type iii 9.8
477 oral squamous cell carcinoma 9.8
478 inflammatory myofibroblastic tumor 9.8
479 lymphoma 9.8
480 spinal meningioma 9.8
481 polycystic ovary syndrome 9.8
482 inflammatory spondylopathy 9.8
483 dengue disease 9.8
484 vulva cancer 9.8
485 hereditary spherocytosis 9.8
486 diarrhea 9.8
487 hyperparathyroidism 9.8
488 cholestasis 9.8
489 pyuria 9.8
490 urticaria 9.8
491 hepatitis c 9.8
492 hemangioma 9.8
493 kidney cancer 9.8
494 idiopathic interstitial pneumonia 9.8
495 adenocarcinoma 9.8
496 ischemia 9.8
497 central nervous system disease 9.8
498 histiocytosis 9.8
499 ovary adenocarcinoma 9.8
500 pulmonary fibrosis 9.8
501 secondary syphilis 9.8
502 hyperglycemia 9.8
503 pseudohypoaldosteronism 9.8
504 secretory meningioma 9.8
505 lymphoplasmacyte-rich meningioma 9.8
506 kidney disease 9.8
507 anterolateral myocardial infarction 9.8
508 spondylitis 9.8
509 thyroiditis 9.8
510 chronic kidney disease 9.8
511 nervous system disease 9.8
512 amyloidosis 9.8
513 diabetes insipidus 9.8
514 placental abruption 9.8
515 alopecia 9.8
516 hypoglycemia 9.8
517 hemophilia 9.8
518 haemophilus influenzae 9.8
519 back pain 9.8
520 head injury 9.8
521 headache 9.8
522 syncope 9.8
523 malignant peritoneal mesothelioma 9.8
524 rapidly involuting congenital hemangioma 9.8
525 thrombotic microangiopathy 9.8
526 red cell aplasia 9.8
527 hepatic vascular disease 9.8 THPO SERPINC1 JAK2 IL6 F3 F2
528 hematologic cancer 9.7 THPO MPL KITLG JAK2 IL6 IL3
529 alcohol dependence 9.7
530 spondyloarthropathy 1 9.7
531 aortic valve disease 1 9.7
532 multiple sclerosis 9.7
533 factor viii deficiency 9.7
534 fibrosis of extraocular muscles, congenital, 1 9.7
535 endosteal hyperostosis, autosomal dominant 9.7
536 intussusception 9.7
537 leukemia, acute monocytic 9.7
538 patterson pseudoleprechaunism syndrome 9.7
539 pernicious anemia 9.7
540 pheochromocytoma 9.7
541 pulmonary fibrosis, idiopathic 9.7
542 thyroid cancer, nonmedullary, 2 9.7
543 anemia, hypochromic microcytic, with iron overload 1 9.7
544 enterocolitis 9.7
545 gaucher disease, type i 9.7
546 factor xii deficiency 9.7
547 hemochromatosis, type 1 9.7
548 hydrops fetalis, nonimmune 9.7
549 immune deficiency disease 9.7
550 intracranial hypertension, idiopathic 9.7
551 myasthenia gravis 9.7
552 reticulum cell sarcoma 9.7
553 thymoma, familial 9.7
554 hemophilia a 9.7
555 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 9.7
556 ventricular fibrillation, paroxysmal familial, 1 9.7
557 alpha-thalassemia 9.7
558 nasopharyngeal carcinoma 9.7
559 allergic rhinitis 9.7
560 mycobacterium tuberculosis 1 9.7
561 legionnaire disease 9.7
562 human immunodeficiency virus type 1 9.7
563 bone mineral density quantitative trait locus 8 9.7
564 major affective disorder 8 9.7
565 major affective disorder 9 9.7
566 bone mineral density quantitative trait locus 15 9.7
567 leukemia, acute lymphoblastic 3 9.7
568 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.7
569 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.7
570 hypophosphatemia 9.7
571 hypochromic microcytic anemia 9.7
572 small cell carcinoma 9.7
573 vitamin b12 deficiency 9.7
574 metabolic acidosis 9.7
575 arteritic anterior ischemic optic neuropathy 9.7
576 fibroma 9.7
577 adrenal gland pheochromocytoma 9.7
578 withdrawal disorder 9.7
579 aphasia 9.7
580 crohn's colitis 9.7
581 stuttering 9.7
582 lymphoblastic lymphoma 9.7
583 hypogonadotropic hypogonadism 9.7
584 sensorineural hearing loss 9.7
585 gastric lymphoma 9.7
586 protein-losing enteropathy 9.7
587 acute anterolateral myocardial infarction 9.7
588 gastric ulcer 9.7
589 hydrocephalus 9.7
590 hemiplegia 9.7
591 henoch-schoenlein purpura 9.7
592 sarcoma 9.7
593 miliaria rubra 9.7
594 microcytic anemia 9.7
595 ornithosis 9.7
596 erysipelas 9.7
597 mitral valve insufficiency 9.7
598 patau syndrome 9.7
599 bladder sarcoma 9.7
600 coronary artery vasospasm 9.7
601 optic neuritis 9.7
602 bronchopneumonia 9.7
603 locked-in syndrome 9.7
604 leiomyoma 9.7
605 quadriplegia 9.7
606 crescentic glomerulonephritis 9.7
607 gout 9.7
608 megaloblastic anemia 9.7
609 pure red-cell aplasia 9.7
610 eclampsia 9.7
611 miliaria 9.7
612 autoimmune polyendocrine syndrome 9.7
613 plasmodium falciparum malaria 9.7
614 hypothyroidism 9.7
615 lymphangioma 9.7
616 candidiasis 9.7
617 nodular nonsuppurative panniculitis 9.7
618 panniculitis 9.7
619 communicating hydrocephalus 9.7
620 rheumatic disease 9.7
621 rheumatic fever 9.7
622 neuritis 9.7
623 mononeuritis multiplex 9.7
624 endodermal sinus tumor 9.7
625 gaucher's disease 9.7
626 fallopian tube carcinoma 9.7
627 enthesopathy 9.7
628 transient cerebral ischemia 9.7
629 angiodysplasia 9.7
630 agammaglobulinemia 9.7
631 transitional cell carcinoma 9.7
632 hemoglobinopathy 9.7
633 testicular cancer 9.7
634 substance abuse 9.7
635 acute kidney failure 9.7
636 glioblastoma multiforme 9.7
637 cystic lymphangioma 9.7
638 mucinoses 9.7
639 lipid metabolism disorder 9.7
640 thymoma 9.7
641 bipolar disorder 9.7
642 liposarcoma 9.7
643 plague 9.7
644 gastric adenocarcinoma 9.7
645 protein c deficiency 9.7
646 vaginal discharge 9.7
647 granuloma annulare 9.7
648 thyroid gland follicular carcinoma 9.7
649 gastritis 9.7
650 spindle cell sarcoma 9.7
651 coronary stenosis 9.7
652 rhinitis 9.7
653 adenosquamous carcinoma 9.7
654 ovarian cyst 9.7
655 chronic inflammatory demyelinating polyradiculoneuropathy 9.7
656 demyelinating polyneuropathy 9.7
657 infertility 9.7
658 testicular yolk sac tumor 9.7
659 pulmonary coin lesion 9.7
660 silent myocardial infarction 9.7
661 congestive heart failure 9.7
662 cerebral meningioma 9.7
663 inflammatory breast carcinoma 9.7
664 plasma cell neoplasm 9.7
665 anterior spinal artery syndrome 9.7
666 b-cell lymphoma 9.7
667 peptic ulcer disease 9.7
668 neuroblastoma 9.7
669 gastrointestinal system disease 9.7
670 septic arthritis 9.7
671 actinomycosis 9.7
672 reticulosarcoma 9.7
673 measles 9.7
674 in situ carcinoma 9.7
675 priapism 9.7
676 fasciitis 9.7
677 toxocariasis 9.7
678 tuberculous peritonitis 9.7
679 congenital syphilis 9.7
680 hydrocele 9.7
681 heterotaxy 9.7
682 47,xyy 9.7
683 nsdhl-related disorders 9.7
684 acquired amegakaryocytic thrombocytopenia 9.7
685 acquired hemophilia 9.7
686 acute myeloblastic leukemia without maturation 9.7
687 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 9.7
688 amaurosis fugax 9.7
689 angioimmunoblastic lymphadenopathy with dysproteinemia 9.7
690 fetal hydantoin syndrome 9.7
691 fibrillary glomerulonephritis 9.7
692 fibromatosis 9.7
693 littoral cell angioma of the spleen 9.7
694 macrophage activation syndrome 9.7
695 myelodysplastic syndrome with excess blasts 9.7
696 pasteurella multocida infection 9.7
697 plasmablastic lymphoma 9.7
698 plummer vinson syndrome 9.7
699 retroperitoneal liposarcoma 9.7
700 single ventricular heart 9.7
701 systemic onset juvenile idiopathic arthritis 9.7
702 raynaud phenomenon 9.7
703 aneurysm 9.7
704 hypotonia 9.7
705 hypoxia 9.7
706 tremor 9.7
707 posttransplant acute limbic encephalitis 9.7
708 b-cell non-hodgkin lymphoma 9.7
709 neonatal hypoxic and ischemic brain injury 9.7
710 smoldering systemic mastocytosis 9.7
711 chronic acquired demyelinating polyneuropathy 9.7
712 rare lymphatic malformation 9.7
713 univentricular heart 9.7
714 pouchitis 9.7
715 ovarian fibroma 9.7
716 malignant epithelial tumor of ovary 9.7
717 methotrexate toxicity 9.7
718 acute liver failure 9.7
719 drug-induced autoimmune hemolytic anemia 9.7
720 hyperpigmentation of the skin 9.7
721 polyploidy 9.7
722 monosomy 22 9.7
723 polyendocrinopathy 9.7
724 thyroid carcinoma 9.7
725 precursor t-cell acute lymphoblastic leukemia 9.7
726 diabetes mellitus 9.6 SERPINC1 SELP IL6 IL1B F3 F2
727 hypertension, essential 9.3 SERPINC1 SELP PPBP JAK2 IL6 IL1B
728 malaria 9.2 SERPINC1 SELP IL6 IL3 IL1B F3
729 aplastic anemia 9.0 THPO TET2 SERPINC1 MPL LIF KITLG
730 blood coagulation disease 8.9 THPO SERPINC1 SELP MPL JAK2 IL6
731 asthma 8.8 THPO SELP PPBP KITLG JAK2 IL6

Graphical network of the top 20 diseases related to Thrombocytosis:



Diseases related to Thrombocytosis

Symptoms & Phenotypes for Thrombocytosis

MGI Mouse Phenotypes related to Thrombocytosis:

45 (showing 10, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.34 CD177 CSF2 CSF3 EPO F2 F3
2 immune system MP:0005387 10.3 CD177 CRP CSF2 CSF3 EPO F2
3 cardiovascular system MP:0005385 10.29 CRP CSF2 EPO F2 F3 IL1B
4 homeostasis/metabolism MP:0005376 10.25 CRP CSF2 EPO F2 F3 IL1B
5 embryo MP:0005380 10.11 CSF2 EPO F2 F3 JAK2 KITLG
6 integument MP:0010771 10.06 CSF2 CSF3 EPO F2 F3 IL1B
7 mortality/aging MP:0010768 9.97 CSF2 EPO F2 F3 IL1B IL6
8 liver/biliary system MP:0005370 9.86 EPO IL6 JAK2 KITLG LIF SELP
9 neoplasm MP:0002006 9.5 CSF2 F3 IL1B IL6 JAK2 KITLG
10 respiratory system MP:0005388 9.23 CSF2 EPO F2 F3 IL6 JAK2

Drugs & Therapeutics for Thrombocytosis

Drugs for Thrombocytosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 167, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
tannic acid Approved Phase 4 1401-55-4
2
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
3
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
4
Anagrelide Approved Phase 3 68475-42-3 2182
5
Peginterferon alfa-2a Approved, Investigational Phase 3 198153-51-4 5360545
6
Peginterferon alfa-2b Approved Phase 3 215647-85-1, 99210-65-8
7
Hydroxyurea Approved Phase 3 127-07-1 3657
8
Mercaptopurine Approved Phase 3 50-44-2 667490
9
Melphalan Approved Phase 3 148-82-3 4053 460612
10
Danazol Approved Phase 3 17230-88-5 28417
11
Cytarabine Approved, Experimental, Investigational Phase 3 147-94-4, 65-46-3 6253
12
Lactitol Investigational Phase 2, Phase 3 585-86-4, 585-88-6 493591
13 Anti-Inflammatory Agents Phase 3
14 Anti-Inflammatory Agents, Non-Steroidal Phase 3
15 Analgesics, Non-Narcotic Phase 3
16 Antipyretics Phase 3
17 Analgesics Phase 3
18 Cyclooxygenase Inhibitors Phase 3
19 Fibrinolytic Agents Phase 2, Phase 3
20 Platelet Aggregation Inhibitors Phase 2, Phase 3
21 Interferon-alpha Phase 2, Phase 3
22 Protein Kinase Inhibitors Phase 3
23 N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide Phase 3
24 Hormones Phase 3
25 Immunologic Factors Phase 3
26 Anti-Infective Agents Phase 3
27 Antiviral Agents Phase 3
28 Mitogens Phase 3
29 Androgens Phase 3
30 Interferon alpha-2 Phase 3
31 Hormone Antagonists Phase 3
32 Estrogens Phase 3
33 Hepcidins Phase 3
34 Estrogen Receptor Antagonists Phase 3
35 Estrogen Antagonists Phase 3
36 interferons Phase 3
37 Janus Kinase Inhibitors Phase 3
38 glucocorticoids Phase 3
39
Panobinostat Approved, Investigational Phase 1, Phase 2 404950-80-7 6918837
40
Nicotinamide Approved, Investigational Phase 2 98-92-0 936
41
Methylprednisolone hemisuccinate Approved Phase 2 2921-57-5
42
Pomalidomide Approved Phase 2 19171-19-8
43
Methylprednisolone Approved, Vet_approved Phase 2 83-43-2 6741
44 Prednisolone acetate Approved, Vet_approved Phase 2 52-21-1
45
Prednisolone phosphate Approved, Vet_approved Phase 2 302-25-0
46
Prednisolone Approved, Vet_approved Phase 2 50-24-8 5755
47
Prednisone Approved, Vet_approved Phase 2 53-03-2 5865
48
Lenalidomide Approved Phase 2 191732-72-6 216326
49
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
50
leucovorin Approved Phase 2 58-05-9 6006 143
51
Aldesleukin Approved Phase 1, Phase 2 110942-02-4, 85898-30-2
52
Decitabine Approved, Investigational Phase 2 2353-33-5 451668
53
Mirabegron Approved Phase 2 223673-61-8 9865528
54
Clopidogrel Approved Phase 2 120202-66-6, 113665-84-2 60606
55
Ticagrelor Approved Phase 2 274693-27-5 9871419
56
Busulfan Approved, Investigational Phase 2 55-98-1 2478
57
Azacitidine Approved, Investigational Phase 1, Phase 2 320-67-2 9444
58
Venetoclax Approved, Investigational Phase 1, Phase 2 1257044-40-8 49846579
59
Topotecan Approved, Investigational Phase 2 119413-54-6, 123948-87-8 60700
60
Carboplatin Approved Phase 2 41575-94-4 10339178 498142 38904
61
Pembrolizumab Approved Phase 2 1374853-91-4
62
Thiotepa Approved, Investigational Phase 2 52-24-4 5453
63
Tacrolimus Approved, Investigational Phase 2 104987-11-3 445643 439492 6473866
64
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
65
Fludarabine Approved Phase 2 21679-14-1, 75607-67-9 30751
66
Mycophenolic acid Approved Phase 2 24280-93-1 446541
67
Vidarabine Approved, Investigational Phase 2 24356-66-9 32326 21704
68
Sodium citrate Approved, Investigational Phase 2 68-04-2
69
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
70
Lenograstim Approved, Investigational Phase 2 135968-09-1
71
Iron Approved, Experimental Phase 1, Phase 2 7439-89-6, 15438-31-0 23925 27284
72
nivolumab Approved Phase 2 946414-94-4
73
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
74
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938